[Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
D000328:Adult; D003692:Delayed-Action Preparations; D004361:Drug Tolerance; D005476:Fluphenazine / Q000008:administration & dosage* / Q000009:adverse effects; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations; D010259:Paranoid Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D005476:Fluphenazine
Essai d'utilisation d'un neuroleptique retard l'oenanthate de fluphénazine (Moditen-retard, Lab. Squibb.